PatientsVille.com Logo

ASPIRATION and MEPROBAMATE

PatientsVille

ASPIRATION Symptoms and Causes

A biopsy is a procedure that removes cells or tissue from your body. A doctor called a pathologist looks at the cells or tissue under a microscope to check for damage or disease. The pathologist may also do other tests on it.

Biopsies can be done on all parts of the body. In most cases, a biopsy is the only test that can tell for sure if a suspicious area is cancer. But biopsies are performed for many other reasons too.

There are different types of biopsies. A needle biopsy removes tissue with a needle passed through your skin to the site of the problem. Other kinds of biopsies may require surgery.

Check out the latest treatments for ASPIRATION

ASPIRATION treatment research studies

MEPROBAMATE clinical trials, surveys and public health registries


Find Drug Side Effect reports



MEPROBAMATE Side Effects

Toxicity To Various Agents (14)
Respiratory Arrest (6)
Cardiac Arrest (6)
Pulmonary Oedema (5)
Completed Suicide (5)
Death (5)
Loss Of Consciousness (4)
Depressed Level Of Consciousness (3)
Excoriation (3)
Contusion (3)
Cardiovascular Insufficiency (3)
Aspiration (3)
Extrapyramidal Disorder (3)
Fall (3)
Suicide Attempt (3)
Respiratory Depression (3)
Pulmonary Congestion (3)
Hypothermia (3)
Pancreatitis Acute (3)
Circulatory Collapse (2)
Cardiomegaly (2)
Coma (2)
Dyspnoea (2)
Hypotension (2)
Drowning (2)
Convulsion (2)
Vomiting (2)
Malaise (2)
Injury (2)
Peripheral Ischaemia (2)
Oropharyngeal Pain (2)
Unresponsive To Stimuli (2)
Salivary Hypersecretion (2)
Neonatal Respiratory Distress Syndrome (1)
Normal Pressure Hydrocephalus (1)
Intentional Overdose (1)
Lung Disorder (1)
Obesity (1)
Left Ventricular Hypertrophy (1)
Laryngeal Disorder (1)
Intentional Self-injury (1)
Pneumonia (1)
Pain In Extremity (1)
Overdose (1)
Oedema Peripheral (1)
Pallor (1)
Pelvic Inflammatory Disease (1)
Portal Triaditis (1)
Poisoning (1)
Premature Baby (1)

➢ More


Common Meds

Abilify (10132)
Adderall (1304)
Amlodipine (6664)
Amoxicillin (4387)
Benadryl (1568)
Celebrex (12876 )
Celexa (1342)
Cialis (2975)
Cipro (8580)
Citalopram (7792)
Crestor (18839)
Cymbalta (14373)
Doxycycline (1757)
Effexor (7289)
Flexeril (435)
Flomax (2177)
Fluoxetine (4261)
Gabapentin (4593)
Hydrocodone (2469)
Ibuprofen (8222)
Lantus (10968)
Lexapro (3499)
Lipitor (17769)
Lisinopril (8919)
Lyrica (27148)
Medrol (650)
Mirena (41254)
Mobic (957)
Morphine (5356)
Naproxen (538)
Neurontin (6501)
Oxycodone (4438)
Pradaxa (13372)
Prednisone (5926)
Prilosec (2631)
Prozac (1954)
Seroquel (27216)
Simvastatin (8348)
Synthroid (4452)
Tamiflu (5585)
Topamax (3748)
Tramadol (5054)
Trazodone (1458)
Viagra (5394)
Vicodin (1153)
Wellbutrin (6324)
Xanax (2847)
Zocor (5718)
Zoloft(6792)
Zyrtec(1669)

ASPIRATION Clinical Trials and Studies

Treatments might be new drugs or new combinations of drugs, new surgical procedures or devices, or new ways to use existing treatments. The goal of clinical trials is to determine if a new test or treatment works and is safe. Clinical trials can also look at other aspects of care, such as improving the quality of life for people with chronic illnesses. People participate in clinical trials for a variety of reasons. Healthy volunteers say they participate to help others and to contribute to moving science forward. Participants with an illness or disease also participate to help others, but also to possibly receive the newest treatment and to have the additional care and attention from the clinical trial staff.
Rank Status Study
1 Recruiting Intrapleural Minocycline After Simple Aspiration for the Prevention of Primary Spontaneous Pneumothorax
Condition: Pneumothorax
Interventions: Procedure: Simple Aspiration with minocycline pleurodesis;   Procedure: simple Aspiration
Outcome Measures: to compare the rates of ipsilateral recurrence between the minocycline and observation groups after simple Aspiration of the pneumothorax.;   Safety profile of minocycline pleurodesis;   Early results, including immediate success rates, one-week success rates, complication rates, rates of hospitalization, duration of hospitalization, and the degrees of chest pain.;   Long-term effects of minocycline pleurodesis, including degrees of residual chest pain and pulmonary function test
2 Unknown  Thrombus Aspiration for OcLuded Coronary Artery Enhanced With Distal Injection Of Abciximab
Conditions: Myocardial Infarction;   Occlusive Thrombus
Interventions: Other: Intracoronary direct injection;   Other: Intracoronary and distal injection by Aspiration device;   Other: Intracoronary distal injection by Aspiration catheter device
Outcome Measures: Infarct size;   Major Adverse Cardiac and Cerebrovascular Events (MACCE)
3 Recruiting Physiologic Assessment of Thrombus Aspiration in Acute ST-segment Elevation Myocardial Infarction Patients
Condition: Myocardial Infarction
Interventions: Device: Eliminate Aspiration catheter;   Procedure: Conventional primary angioplasty
Outcome Measures: IMR (mmHg seconds) in thrombus Aspiration compared to conventional PCI group;   Resolution of ST-segment elevation;   myocardial blush grade (0-3);   infarct size assessed by peak enzyme release (Troponin, creatine kinase MB (CK-MB));   indices of left ventricle remodeling on Echocardiography;   infarct size determined by SPECT
4 Recruiting Aspiration of Residual Gastric Contents
Conditions: Infant, Premature;   Nutrition, Enteral
Interventions: Procedure: No Aspiration of gastric contents;   Procedure: Routine Aspiration of gastric contents
Outcome Measures: 24-hour enteral feeding intake in mL/kg;   Time to reach full feeds;   Hours receiving parenteral nutrition;   Weekly or biweekly liver function tests;   Hours of central venous line access;   Episodes of late onset sepsis;   Growth indices;   Length of hospital stay;   Episodes of necrotizing enterocolitis;   Presence of blood in stools;   Level of fecal calprotectin;   serum gastrin level;   motilin level;   tracheal pepsin levels;   presence of Aspiration pneumonia;   presence of ventilator associated pneumonia
5 Recruiting Salpingectomy Versus Aspiration of Hydrosalpingeal Fluid Prior to IVF-ET
Condition: Infertility
Interventions: Procedure: Needle Aspiration of hydrosalpinx;   Procedure: Salpingectomy
Outcome Measures: The Number of Participants Who Achieved Clinical Pregnancy in a Transfer Cycle;   The Number of Participants Who Achieved Ongoing Pregnancy in a Transfer Cycle .
6 Recruiting Virtual Bronchoscopy (VB) vs. Endobronchial Ultrasound (EBUS) Guided Mediastinal Sampling
Conditions: Lung Cancer,;   Mediastinal Tumors,;   Lymphomas,;   Sarcoidosis,
Interventions: Procedure: virtual bronchoscopy guided transbronchial needle Aspiration;   Procedure: endobronchial ultrasound guided transbronchial needle Aspiration
Outcome Measures: Adequacy of cytologic specimens collected by VB-TBNA vs. EBUS-TBNA;   Diagnostic accuracy of VB-TBNA vs. EBUS-TBNA - the number (and percentage) of cytologic specimens containing diagnostic material (neoplastic cells, granulomas)
7 Recruiting Comparison of Gastric Bypass and AspireAssist Aspiration Therapy for Treatment of Morbid Obesity
Condition: Obesity
Interventions: Procedure: Gastric Bypass;   Device: AspireAssist Aspiration Therapy
Outcome Measures: Weight Loss;   Quality of Life
8 Recruiting Sellick Interest in Rapid Sequence Induction
Conditions: Rapid Sequence Induction of General Anesthesia;   Sellick Maneuver;   Acid Aspiration Syndrome;   Lung Aspiration;   Aspiration Pneumonia
Interventions: Other: effective sellick maneuver;   Other: sham sellick maneuver
Outcome Measures: Incidence of lung Aspiration;   Cormack and Lehane Grade;   Frequency of use of a mask ventilation;   Number of times the Sellick maneuver should be discontinued;   Effects of releasing the Sellick maneuver on the conditions of tracheal intubation assessed by Cormack and Lehane grade;   Incidence of difficult and impossible intubation;   Incidence of Aspiration pneumonia;   Incidence of oesophageal rupture;   Incidence of cricoid cartilage fracture;   Mortality
9 Unknown  Aspiration Device in Myocardial Infarction Trial
Condition: Angioplasty
Intervention: Device: repeated thrombus Aspiration during primary PCI
Outcome Measures: Limitation of infarct size;   Early and follow up related (MACE)-major adverse cardiac events;   Efficacy of using Aspiration device after every stage of Primary angiplasty
10 Recruiting Trial of Endobronchial Ultrasound Guided Fine Needle Aspiration Techniques
Condition: Lung Cancer
Intervention: Device: EBUS guided FNA with and without suction
Outcome Measures: Sensitivity of each needle Aspiration technique for diagnosis of malignancy;   Diagnostic accuracy of each needle Aspiration technique for diagnosis of malignancy;   Adequacy of the needle Aspiration sample;   Negative predicted value of each needle Aspiration technique for diagnosis of malignancy;   Specificity of each needle Aspiration technique for diagnosis of malignancy;   Positive predicted value of each needle Aspiration technique for diagnosis of malignancy
11 Unknown  Thrombus Aspiration During Percutaneous Coronary Intervention in Acute Non-ST-elevation Myocardial Infarction Study
Condition: Non-ST-Elevation Myocardial Infarction
Interventions: Procedure: Thrombus Aspiration followed by stent implantation;   Procedure: conventional PCI
Outcome Measures: Incidence of myocardial blush grade 3 after PCI;   Coronary angiographic outcomes;   Histopathological outcomes of atherothrombotic material;   Enzymatic infarct size;   Electrocardiographic outcomes;   Clinical outcomes at 30 days and 1 year
12 Recruiting Efficacy of Combining Pasireotide With Aspiration Ssclerotherapy to Improve Volume Reduction of Hepatic Cysts
Condition: Symptomatic Dominant Liver Cyst
Interventions: Drug: Pasireotide LAR 60 mg;   Procedure: Aspiration sclerotherapy;   Drug: Placebo
Outcome Measures: Proportional diameter change;   Absolute reduction (cm) hepatic cyst;   Proportional (%) and absolute cyst reduction (cm) after 12 weeks;   Proportion cyst recurrence;   Symptomatic change and health-related quality of life;   Safety
13 Unknown  Comparison Of Surfactant Lung Lavage With Standard Care In The Treatment Of Meconium Aspiration Syndrome
Condition: Meconium Aspiration Syndrome
Intervention: Drug: Bovine surfactant
Outcome Measures: duration of oxygen therapy in hours;   Severity of respiratory distress;   need for mechanical ventilation;   Duration of mechanical ventilation;   Complications;   Incidence of sepsis;   Mortality;   Duration of Hospital stay
14 Unknown  Trial of an Oral Sucrose Solution Versus Placebo in Children 1 to 3 Months Old Needing Nasopharyngeal Aspiration
Condition: Pain
Interventions: Drug: 88% sucrose po;   Drug: placebo po
Outcome Measures: Difference in pains scores related to nasopharyngeal Aspiration;   Difference in pain scores related to nasopharyngeal Aspiration
15 Unknown  Modified Stereotactic Aspiration and Thrombolysis of Intracerebral Hemorrhage:a Multi-center Controlled Study
Condition: Hypertensive Intracerebral Hemorrhage
Interventions: Device: Stereotactic Aspiration and Thrombolysis;   Drug: conservative treatment
Outcome Measures: The rate of rebleeding and mortality, Glasgow Outcome Scale for prognosis;   Nation of Health Stroke Scale Score , modified Rankin Scale, Barthel Index complications
16 Recruiting Suprapubic Aspiration Versus Urinary Catheterization In Neonates.
Condition: Neonatal Urinary Tract Infection
Interventions: Procedure: Suprapubic Aspiration;   Procedure: Urinary Catheterization
Outcome Measures: Number of contaminated urine samples per SPA and UC;   Success rates of obtaining urine by SPA versus UC;   Time to perform the respective procedures;   Complication rates of SPA versus UC;   Contamination rates of SPA versus UC (excluding clean catch urine);   Number of attempts per procedure
17 Unknown  Surfactant Lavage vs. Bolus Surfactant in Neonates With Meconium Aspiration
Condition: Meconium Aspiration Syndrome
Interventions: Drug: Bovine Lipid Extract Surfactant (administered by lavage);   Drug: Bovine Lipid Extract Surfactant (administered by bolus)
Outcome Measures: % change in oxygenation indices from baseline to 1 and 6 h following treatment;   % change in dynamic pulmonary compliance from baseline to 1 and 6 h following treatment;   % change in pulmonary artery pressure from baseline to 1 and 6 h following treatment;   measures of efficacy of ventilation and oxygenation at 1 h and 6 h following treatment;   cardiac function by echocardiography at 6 hours following treatment;   % change in oxygenation indices, dynamic pulmonary compliance and pulmonary vascular resistance from baseline to 12, 24 and 48 h following treatment;   measures of efficiency of ventilation and oxygenation at 12, 24 and 48 h following treatment;   duration of mechanical ventilation, defined as the cumulative time of mechanical ventilation;   length of time on CPAP;   length of time with oxygen supplementation;   length of time on inotropes and maximum inotropic score.;   need for and length of use of NO;   need for and length of use of ECMO;   time to full enteral feeds;   attainment of exit criteria;   development of significant pulmonary hemorrhage;   development of significant intracranial hemorrhage;   development of tension pneumothorax requiring drainage;   need for repeat surfactant;   length of stay in a level III NICU;   mortality
18 Unknown  Magnetic Acupressure in Reducing Pain in Cancer Patients Undergoing Bone Marrow Aspiration and Biopsy
Conditions: Brain and Central Nervous System Tumors;   Chronic Myeloproliferative Disorders;   Leukemia;   Lymphoma;   Lymphoproliferative Disorder;   Multiple Myeloma and Plasma Cell Neoplasm;   Myelodysplastic Syndromes;   Myelodysplastic/Myeloproliferative Neoplasms;   Pain;   Precancerous Condition;   Unspecified Adult Solid Tumor, Protocol Specific
Interventions: Other: questionnaire administration;   Procedure: acupressure therapy;   Procedure: biopsy;   Procedure: bone marrow Aspiration;   Procedure: pain therapy
Outcome Measures: Pain scores before and during bone marrow Aspiration and biopsy (BMAB) as measured by a patient-reported 11-point visual analogue pain scale;   Clinical benefit response as measured by duration of BMAB, patient's rating of the procedure, and patient's willingness to receive acupressure during subsequent BMAB
19 Not yet recruiting Comparing Newly Developed PreCore Needle With Conventional Fine Needle in Suspected Unresectable Pancreatic Cancer
Condition: Pancreatic Cancer
Interventions: Device: 22 gauge ProCore needle Aspiration;   Device: 22 gauge Fine needle Aspiration
Outcome Measures: The rates of diagnostic sufficiency;   The presence of histologic core
20 Unknown  Effects of Tracheal Tube Size on Pulmonary Aspiration
Condition: The Reduction of Aspiration Rate in Intubated Patients
Intervention: Other: Observation of fluid leakage around tracheal tube cuffs
Outcome Measure: Aspiration rate